We will continue to monitor the GLP-1 pipeline and evolve our formulary strategies to help drive competition and lower costs as new drugs come to market
Administration routes include subcutaneous injection (via syringe, pen, or continuous subcutaneous insulin infusion pump), intravenous infusion (restricted to monitored clinical settings), and, more recently, inhaled insulin for prandial coverage
As you lose significant weight, the dose of levothyroxine that was previously correct for you may become too high, potentially causing symptoms of an overactive thyroid (hyperthyroidism) such as palpitations, anxiety, and tremors
General considerations when you are deciding whether GLP-1 agonists or tirzepatide are right for you: GLP-1 agonists increase hormones called incretins
Avvertenze e controindicazioni Non superare la dose giornaliera raccomandata